Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma
- 31 August 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 87 (2) , 146-150
- https://doi.org/10.1016/s1081-1206(10)62210-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Bronchial Hyperresponsiveness, Hypersensitivity to Analgesics and Urinary Leukotriene E4 Excretion in Patients with Aspirin–Intolerant AsthmaInternational Archives of Allergy and Immunology, 1998
- Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthmaClinical and Experimental Allergy, 1998
- Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.Journal of Clinical Investigation, 1998
- Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.American Journal of Respiratory and Critical Care Medicine, 1996
- Increased urinary excretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstructionJournal of Allergy and Clinical Immunology, 1996
- ASPIRIN-INDUCED ASTHMABritish Journal of Anaesthesia, 1993
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Aspirin and concomitant idiosyncrasies in adult asthmatic patientsJournal of Allergy and Clinical Immunology, 1979
- The diagnosis of aspirin idiosyncrasy by analgesic challengeClinical and Experimental Allergy, 1976
- Aspirin intolerance in asthma *1, *2Detection by oral challengeJournal of Allergy and Clinical Immunology, 1972